A fixed dose combination drug for type 2 diabetes has been launched by Pharma giant Glenmark Pharmaceuticals. Glenmark has launched the same under two brand names -- Remo MV and Remozen MV.
from Medindia Health News https://ift.tt/3vN8JKj
via
Union Health Minister Mansukh Mandaviya has urged everyone who has not been vaccinated to get vaccinated, so they can contribute to this historic golden vaccination journey of India. from Medindia Health News https://ift.tt/3m2rDde via
Young children are rapidly forming memories of new words, they are also losing a lot of memories. When we form a memory, it includes the context: where, when, what else was going on. from Medindia Health News https://ift.tt/3aXIB5X via
A new targeted contrast agent to detect and image blood clots non-invasively has been developed. The agent has a strong affinity for fibrin, a component of blood clots. from Medindia Health News https://ift.tt/3GR0Icr via
A fixed dose combination drug for type 2 diabetes has been launched by Pharma giant Glenmark Pharmaceuticals. Glenmark has launched the same under two brand names -- Remo MV and Remozen MV.
Comments
Post a Comment